NCT00628238 2010-09-10Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia Research ConsortiumPhase 2 Unknown80 enrolled
NCT00800943 2008-12-03CRC005Chronic Lymphocytic Leukemia Research ConsortiumPhase 2 Unknown31 enrolled